NU 578

Focus: Unit 1 – 5

Topics Include: Pharmacokinetics / Pharmacodynamics, Controlled substances, Adverse drug reactions, Pregnancy, Pediatrics, Older adults, Physiology of the peripheral nervous system, CNS pharmacology, Parkinson disease, Alzheimer’s disease, Multiple sclerosis, Seizures disorders, Muscle spasms and spasticity, Local anesthetics, General anesthetics, Opioid analgesics, Pain management, Headaches, Antipsychotics, Antidepressants, Bipolar disorder, Sedative-Hypnotic drugs, Anxiety disorders, ADHD, Substance use disorders, DEA schedules, Fluid & electrolyte balance, Heart and blood vessels, RAAS, Hypertension, Heart failure, Angina pectoris, Acute STEMI, Hemophilia, Deficiency anemias, Hematopoietic agents, Asthma / COPD, Allergic rhinitis / Cough, Diabetes mellitus, Thyroid disorders, Hypothalamic and pituitary function, Birth control, Infertility, Uterine function, ED and BPH, Immune system, Rheumatoid arthritis, Gout, GI disorders, Antimicrobial therapy, UTIs, STIs, Drugs for eyes / ears, Poisoning, Bioterrorism

Drug Classes: Muscarinic agonists / antagonists, Cholinesterase inhibitors, Adrenergic agonists / antagonists, Indirect-acting antiadrenergic agonists, Benzodiazepines, Antipsychotics, Barbiturates, SSRI, SNRI, Amphetamines, Diuretics, ACE inhibitors, ARBs, CCBs, Vasodilators, Beta-blockers, Antidysrhythmics, Statins, Nitrates, Anticoagulants, Antiplatelets, Fibrinolytics, Factor VIII / IX concentrates, Inhalers (SABA, LABA, LAMA, ICS), Antihistamines, Antitussives, Expectorants, Mucolytics, Insulin, Biguanides, DDP-4 inhibitors, Glitazones, Sulfonylureas, SGLT-2, GLP-1, Amlyin mimetic, Antidiuretic hormone, Contraceptives, Prostaglandins, Androgens, 5-alpha reductase inhibitors, alpha1 blockers, PDE5 inhibitors, Glucocorticoids, NSAIDs, Antibiotics, Chemotherapy, Antimalarials